AMD3100 augments the efficacy of mesothelin-targeted, immune-activating VIC-008 in mesothelioma by modulating intratumoral immunosuppression
Li, Binghao, Zeng, Yang, Reeves, Patrick M, Ran, Chongzhao, Liu, Qiuyan, Qu, Xiying, Liang, Yingying, Liu, Zhao, Yuan, Jianping, Leblanc, Pierre R, Ye, Zhaoming, Sluder, Ann E, Gelfand, Jeffrey A, BraLanguage:
english
Journal:
Cancer Immunology Research
DOI:
10.1158/2326-6066.CIR-17-0530
Date:
March, 2018
File:
PDF, 7.77 MB
english, 2018